About: http://data.cimple.eu/news-article/4b983226c099f9a37f3c6408433b06b51bfe1ed80b7a533d11d0e728

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/4b983226c099f9a37f3c6408433b06b51bfe1ed80b7a533d11d0e728 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	BioNTech said Thursday that it expected its Covid-19 vaccine, jointly developed with Pfizer, to be available to 12 to 15-year-olds in Europe from June. The German firm's CEO Ugur Sahin told Der Spiegel weekly that it was "in the final stretches" of preparing its submission for European regulatory approval. The evaluation of the trial data "takes four to six weeks on average", he added. Vaccinating children is seen as a crucial next step toward herd immunity and ending the pandemic. The prospect of getting older children inoculated before the next school year starts would also relieve the strain on parents who are juggling the demands of homeschooling while keeping up with jobs. "It's very important to enable children a return to their normal school lives and allow them to meet with family and friends," Sahin told Spiegel. BioNTech/Pfizer already applied for emergency US authorisation of their jab for 12 to 15-year-olds earlier this month. Sahin expects to submit a similar request to the European Medicines Agency (EMA) next Wednesday, he told Spiegel. The move comes after BioNTech and Pfizer in late March announced that phase 3 clinical trials of their vaccine for children aged 12-15 showed it was 100 percent effective in warding off the disease. Both companies are also racing to get the jab approved for younger children, from six months upwards. "In July, the first results for five to 12-year-olds could be available, and those for younger children in September," he said. Ongoing trials so far are "very encouraging", Sahin said, suggesting that "children are very well protected by the vaccine". The BioNTech/Pfizer shot is based on novel mRNA technology and was the first Covid-19 jab to be approved in the West late last year. ys-mfp/hmn/spm
schema:headline	BioNTech eyes Covid vaccine for 12-15 year olds from June in EU
schema:mentions	Juggling Homeschooling Herd immunity Der Spiegel European Medicines Agency Jab Messenger RNA Chief executive officer European Union Pandemic Pfizer Coronavirus disease Vaccine Coronavirus disease 2019 Normal school The Move
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-04-29 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	76 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software